Pediatricians and pharmacies across the state are reporting critical shortages in amoxicillin and Adderall. TPS will continue to provide updates as they become available. Below is information on the drug shortages and resources for additional updates. 

Amoxicillin Update
On October 28, the Federal Drug Administration (FDA) listed 23 Amoxicillin products on its drug shortage site due to increased demand. TPS has received an update from the Texas Pharmacy Association, who is reporting that the supply is limited across the state. It is thought that the increase in demand, coupled with supply chain issues, is impacting the availability and may be impacted at least through the end of 2022. 

Physicians and providers are encouraged to check the FDA website and the American Society of Health Systems Pharmacy (ASHP)/University of Utah Drug Shortage Database to learn more about amoxicillin availability and estimated resupply dates. These sites will continue to be updated as more information is available. Additionally, the American Academy of Pediatrics' (AAP) reporting on the shortage includes some clinical guidance to help maintain antibiotic supply and prevent resistance. 

Adderall Update 
The FDA has also posted a shortage of the immediate release formulation of amphetamine mixed salts, commonly known as Adderall. The short began in October with multiple manufacturers experiencing supply issues and the FDA expects the shortage to continue through the end of the year.  

Physicians can check the availability of Adderall and alternative product strengths on the FDA website and learn more about resupply dates and availability on the ASHP/University of Utah Drug Shortage Database. The AAP has also released a news article on additional treatment options available during the shortage. 

Thank you for all you do for Texas children! If you have questions or would like more information, please contact Allison McHorse, TPS Policy Associate, or Stacey Mather, TPS Executive Director.